Sleep Assessment in CML (CML-SLEEP)
OBJECTIVE AND SUBJECTIVE ASSESSMENT OF SLEEP QUALITY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
Sponsor: HaEmek Medical Center, Israel
Listed as NCT03353558, this observational or N/A phase trial focuses on Chronic Myeloid Leukemia and Sleep Disorder and remains ongoing. Sponsored by HaEmek Medical Center, Israel, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status
-
Dec 2019 — Feb 2020 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2019 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- HaEmek Medical Center, Israel
- The Max Stern Academic College Of Emek Yezreel
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.